No Detail Found!

Effect of recombinant follicular stimulating hormone and human menopausal gonadotrophins on the oocytes number in patients undergoing assisted reproductive technique

Author(s)
Rabia Nafees Department of Obstetrics & Gynecology, Postgraduate Medical Institute, Ameer-Ud-Din Medical College, Lahore General Hospital, Lahore, Pakistan.
Yousaf Latif Khan Department of Obstetrics & Gynecology, Postgraduate Medical Institute, Ameer-Ud-Din Medical College, Lahore General Hospital, Lahore, Pakistan.
Haroon Latif Khan Department of Obstetrics & Gynecology, Postgraduate Medical Institute, Ameer-Ud-Din Medical College, Lahore General Hospital, Lahore, Pakistan.
Aisha Awais Department of Obstetrics & Gynecology, Postgraduate Medical Institute, Ameer-Ud-Din Medical College, Lahore General Hospital, Lahore, Pakistan.
Nighat Mahmood Department of Obstetrics & Gynecology, Postgraduate Medical Institute, Ameer-Ud-Din Medical College, Lahore General Hospital, Lahore, Pakistan.
Saba Sardar Department of Obstetrics & Gynecology, Postgraduate Medical Institute, Ameer-Ud-Din Medical College, Lahore General Hospital, Lahore, Pakistan.
Rameen Nisar Department of Obstetrics & Gynecology, Postgraduate Medical Institute, Ameer-Ud-Din Medical College, Lahore General Hospital, Lahore, Pakistan.
Abstract
The data regarding the eefctiveness of various protocols used for controlled ovarian stimulation (COS) in assisted reproductive techniques (ART) in our own population is scant. This study compares recombinant follicular stimulating hormone (rFSH) and human menopausal gonadotrophins (HMG) in terms of follicular numbers and oocytes retrieved in Pakistani women undergoing ART. Methods: A total of 300 patients were selected out of 1,950 patients who visited the hospital for in vitro fertilization/intra cytoplasmic sperm insemination (IVF/ICSI) from June 2018 to December 2020. These patients were further divided into two categories: first category (1) was given long protocol and the second category (2) was given short antagonist protocol. Each category was further sub-divided into two groups; group A who received HMG, and group B who received rFSH for COS. Results: There was a significantly higher number of follicles and oocytes retrieved in category 1, with rFSH (20.01 ± 4.91, 15.19 ± 9.18) versus. HMG (16.07 ± 5.67, 11.10 ± 5.07) with a p-value (0.00, 0.004). On the other hand, in category 2, the number of follicles was insignificant (p-value = 0.319) in both groups. Contrary to that the number of oocytes retrieved was significantly higher with a p-value of = 0.05 in both groups. Conclusion: In COS in ART, long protocol with rFSH has much beetr results both in terms of follicular numbers and retrieved oocytes. While for the short protocol with the antagonist, rFSH has been demonstrated to be superior to HMG but that is limited to the number of oocytes.
Publication Details
Page(s) 170-174
Published Journal: Biomedica, Volume: 37, Issue: 3, Year: 2021

Request the full text from PASTIC

Keywords
human menopausal gonadotrophins, Controlled ovarian stimulation, recombinant follicular stimulating hormone, Assisted reproductive technology, in vitro fertilization
References
Akhondi MM,Ranjbar F,Shirzad M,Ardakani ZB,Kamali K,Mohammad K. .2019 .Practical difficulties in estimating the prevalence of primary infertility in Iran. Int J Fertil Steril, 13(2) : 113-7.
Ahmed HM,Khan M,Yasmin F,Jawaid H,Khalid H,Shigri A .2020 .Awareness regarding causes of infertility among outpatients at a tertiary care hospital in Karachi, Pakistan. , 12(4) : 1-10.
.2013 .cited 2020 Jan]. NICE Clinical Guideline, : .
Pirtea P,de Ziegler D,Poulain M,Ayoubi JM .2020 .Which key performance indicators are optimal to assess clinical management of assisted reproduction cycles? Fertil Steril. , 04(1) : 24-30.
Haahr T,Esteves SC,Humaidan P .2018 .Individualized controlled ovarian stimulation in expected poor-responders: an update. Reprod Biol Endocrinol, 16(1) : 1-9.
Alper MM,Fauser BC .2017 .Ovarian stimulation protocols for IVF: is better than less? Reprod Biomed Online. , 01(4) : 345-53.
Orvieto R. .2019 .HMG versus recombinant FSH plus recombinant LH in ovarian stimulation for IVF: does the source of LH preparation matter? Reprod Biomed. , 08(6) : 1001-6.
Shavit T,Shalom-Paz E,Samara N,Aslih N,Michaeli M,Ellenbogen A .2016 .Comparison between stimulation with highly purified HMG or recombinant FSH in patients undergoing IVF with GnRH antagonist protocol. Gynecol Endocrinol, 32(8) : 629-33.
Bosch E,Broer S,Griesinger G,Grynberg M,Humaidan P,Kolibianakis E .2020 .ESHRE guideline: ovarian stimulation for IVF/ICSI. , : 1-13.
La Marca A,Sunkara SK .2014 .Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice. Hum Reprod Update, 20(1) : 124-40.
Ramalho de Carvalho B,Gomes Sobrinho DB,Vieira AD,Resende MP,Barbosa AC,Silva AA .2012 .Ovarian reserve assessment for infertility investigation. ISRN Obstet Gynecol, : 1-10.
Galey-Fontaine J,Cédrin-Durnerin I,Chaïbi R,Massin N,Hugues JN .2005 .Age and ovarian reserve are distinct predictive factors of cycle outcome in low responders. Reprod Biomed Online, 6483(10) : 60808-5.
Stolwijk AM,Wetzels AM,Braat DD .2000 .Cumulative probability of achieving an ongoing pregnancy after in-vitro fertilization and intracytoplasmic sperm injection according to a woman's age, subfertility diagnosis and primary or secondary subfertility. Hum Reprod, 15(1) : 203-9.
Rittenberg V,Seshadri S,Sunkara SK,Sobaleva S,OtengNtim E,El-Toukhy T .2011 .Effect of body mass index on IVF treatment outcome: an updated systematic review and metaanalysis. Reprod Biomed, 06(4) : 421-39.
Setti AS,Braga DP,FigueiraRde C,Vingris L,Iaconelli A,Borges E .2012 .Body mass index is negatively correlated with the response to controlled ovarian stimulation but does not influence oocyte morphology in ICSI cycles. Eur J Obstet Gynecol Reprod Biol, 04(2) : 175-9.
Al-Turki HA .2015 .Prevalence of primary and secondary infertility from tertiary center in eastern Saudi Arabia. Middle East Fertil Soc J, 02(4) : 237-40.
Kumar N,Singh AK .2015 .Trends of male factor infertility, an important cause of infertility: a review of literature. J Hum Reprod Sci, 8(4) : 170370-1208.
Shahrokh Tehraninezhad E,Mehrabi F,Taati R,Kalantar V,Aziminekoo E,Tarafdari A .2016 .Analysis of ovarian reserve markers (AMH, FSH, AFC) in different age strata in IVF/ICSI patients. Int J Reprod Biomed, 14(8) : 501-6.
Barad DH,Weghofer A,Gleicher N. .2008 .Comparing antimüllerian hormone (AMH) and follicle-stimulating hormone (FSH) as predictors of ovarian function. Fertil Steril, 09(4 Suppl)) : 1553-5.
Revelli A,Martiny G,Delle Piane L,Benedetto C,Rinaudo P,Tur-Kaspa I. .2014 .A critical review of bi-dimensional and threedimensional ultrasound techniques to monitor follicle growth: do they help improving IVF outcome? Reprod Biol Endocrinol. , 12 : 1477-15.
Andersen AN,Devroey P,Arce JC. .2006 .Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial. Hum Reprod, 21(12) : 3217-27.
Daya S. Updated .2002 .-analysis of recombinant folliclestimulating hormone (FSH) versus urinary FSH for ovarian stimulation in assisted reproduction. Fertil Steril, 0282(01) : 03246-0.
Duan L,Bao S,Li K,Teng X,Hong L,Zhao X .2017 .Comparing the long-acting and short-acting forms of gonadotropin-releasing hormone agonists in the long protocol of IVF/ICSI Cycles: a retrospective study. J Obstet Gynaecol Res, 43(6) : 1037-42.
Ou J,Xing W,Li Y,Xu Y,Zhou C .2015 .Short versus long gonadotropinreleasing hormone analogue suppression protocols in IVF/ ICSI cycles in patients of various age ranges. PLoS One, 10(7) : .
Andersen AN,Devroey P,Arce JC. .2006 .Clinical outcome following stimulation with highly purified HMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial. Hum Reprod, 21(12) : 3217-27.
0

Citations

0

Downloads

17

Views